{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:07:18Z","timestamp":1768392438219,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-025-01315-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:12:44Z","timestamp":1768367564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment"],"prefix":"10.1007","volume":"27","author":[{"given":"Stephanie","family":"Aron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Azari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Nasseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Bagrodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirali","family":"Salmasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"3","key":"1315_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031557","volume":"25","author":"E Gill","year":"2024","unstructured":"Gill E, Perks CM. Mini-review: current bladder cancer treatment-the need for improvement. Int J Mol Sci. 2024;25(3):1557.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1315_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784\u201395.","journal-title":"Eur Urol"},{"issue":"10","key":"1315_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2217\/pgs-2020-0165","volume":"22","author":"T Souaid","year":"2021","unstructured":"Souaid T, Hindy JR, Diab E, Kourie HR. Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities? Pharmacogenomics. 2021;22(10):619\u201328.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"1315_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q","volume":"89","author":"MP Zeegers","year":"2000","unstructured":"Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89(3):630\u20139.","journal-title":"Cancer"},{"issue":"9 Pt B","key":"1315_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1464-410X.2008.07961.x","volume":"102","author":"X Wu","year":"2008","unstructured":"Wu X, Ros MM, Gu J, Kiemeney L. Epidemiology and genetic susceptibility to bladder cancer. BJU Int. 2008;102(9 Pt B):1207\u201315.","journal-title":"BJU Int"},{"issue":"7","key":"1315_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","volume":"87","author":"LB Travis","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin\u2019s lymphoma. J Natl Cancer Inst. 1995;87(7):524\u201330.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1315_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/oxfordjournals.aje.a113768","volume":"119","author":"AF Kantor","year":"1984","unstructured":"Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF. Urinary tract infection and risk of bladder cancer. Am J Epidemiol. 1984;119(4):510\u20135.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1315_CR8","first-page":"407","volume":"73","author":"G Rosiello","year":"2020","unstructured":"Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Martin T, Tian Z, et al. Racial differences in the distribution of bladder cancer metastases: a population-based analysis. Cent Eur J Urol. 2020;73(4):407\u201315.","journal-title":"Cent Eur J Urol"},{"issue":"1","key":"1315_CR9","doi-asserted-by":"publisher","first-page":"2240084","DOI":"10.1080\/15384047.2023.2240084","volume":"24","author":"S Kandalai","year":"2023","unstructured":"Kandalai S, Li H, Zhang N, Peng H, Zheng Q. The human microbiome and cancer: a diagnostic and therapeutic perspective. Cancer Biol Ther. 2023;24(1):2240084.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1315_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, Von Muhlinen N, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19(1):123.","journal-title":"Genome Biol"},{"issue":"13","key":"1315_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1479720","volume":"12","author":"X Wang","year":"2025","unstructured":"Wang X, He X, Zhong B. Oral microbiota: the overlooked catalyst in cancer initiation and progression. Front Cell Dev Biol. 2025;12(13):1479720.","journal-title":"Front Cell Dev Biol"},{"key":"1315_CR12","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/srep14554","volume":"5","author":"P Lehouritis","year":"2015","unstructured":"Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, et al. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5:14554.","journal-title":"Sci Rep."},{"issue":"6371","key":"1315_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103.","journal-title":"Science"},{"key":"1315_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.urology.2018.12.034","volume":"126","author":"P Bajic","year":"2019","unstructured":"Bajic P, Wolfe AJ, Gupta GN. The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics. Urology. 2019;126:10\u20135.","journal-title":"Urology"},{"issue":"6","key":"1315_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","volume":"3","author":"F Pederzoli","year":"2020","unstructured":"Pederzoli F, Ferrarese R, Amato V, Locatelli I, Alchera E, Lucian\u00f2 R, et al. Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder cancer patients. Eur Urol Oncol. 2020;3(6):784\u20138.","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"1315_CR16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/biomedicines10071758","volume":"10","author":"B Mansour","year":"2022","unstructured":"Mansour B, Mony\u00f3k \u00c1, Gajd\u00e1cs M, Stercz B, Makra N, P\u00e9nzes K, et al. Bladder tissue microbiome composition in patients of bladder cancer or benign prostatic hyperplasia and related human beta defensin levels. Biomedicines. 2022;10(7):1758.","journal-title":"Biomedicines"},{"issue":"5","key":"1315_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/apm.13097","volume":"129","author":"N Nadler","year":"2021","unstructured":"Nadler N, Kvich L, Bjarnsholt T, Jensen JB, G\u00f6genur I, Azawi N. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer. APMIS. 2021;129(5):265\u201370.","journal-title":"APMIS"},{"issue":"1","key":"1315_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29054-w","volume":"8","author":"V Bu\u010devi\u0107 Popovi\u0107","year":"2018","unstructured":"Bu\u010devi\u0107 Popovi\u0107 V, \u0160itum M, Chow CET, Chan LS, Roje B, Terzi\u0107 J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8(1):12157.","journal-title":"Sci Rep"},{"key":"1315_CR19","doi-asserted-by":"crossref","unstructured":"Nickel JC, Stephens A, Ackerman AL, Anger JT, Lai HH, Ehrlich GD. The healthy urinary microbiome in asymptomatic participants in the MAPP Network Study: Relation to gender, age, and menopausal status. Can Urol Assoc J [Internet]. 2022 Apr 11 [cited 2025 Sept 23];16(9). Available from: https:\/\/cuaj.ca\/index.php\/journal\/article\/view\/7775.","DOI":"10.5489\/cuaj.7775"},{"issue":"4","key":"1315_CR20","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.3390\/cimb46040225","volume":"46","author":"K Bilski","year":"2024","unstructured":"Bilski K, \u017beber-Lubecka N, Kulecka M, D\u0105browska M, Ba\u0142abas A, Ostrowski J, et al. Microbiome sex-related diversity in non-muscle-invasive urothelial bladder cancer. Curr Issues Mol Biol. 2024;46(4):3595\u2013609.","journal-title":"Curr Issues Mol Biol"},{"issue":"10","key":"1315_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molmed.2023.07.002","volume":"29","author":"M Parizadeh","year":"2023","unstructured":"Parizadeh M, Arrieta MC. The global human gut microbiome: genes, lifestyles, and diet. Trends Mol Med. 2023;29(10):789\u2013801.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1315_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17460913.2024.2414671","volume":"20","author":"L Dadgar-Zankbar","year":"2025","unstructured":"Dadgar-Zankbar L, Mokhtaryan M, Bafandeh E, Javanmard Z, Asadollahi P, Darbandi T, et al. Microbiome and bladder cancer: the role of probiotics in treatment. Future Microbiol. 2025;20(1):73\u201390.","journal-title":"Future Microbiol"},{"issue":"12","key":"1315_CR23","doi-asserted-by":"publisher","first-page":"718776","DOI":"10.3389\/fmicb.2021.718776","volume":"7","author":"M Parra-Grande","year":"2022","unstructured":"Parra-Grande M, Or\u00e9-Arce M, Mart\u00ednez-Priego L, D\u2019Auria G, Rossell\u00f3-Mora R, Lillo M, et al. Profiling the bladder microbiota in patients with bladder cancer. Front Microbiol. 2022;7(12):718776.","journal-title":"Front Microbiol"},{"issue":"7728","key":"1315_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart CJ, Ajami NJ, O\u2019Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583\u20138.","journal-title":"Nature"},{"issue":"3","key":"1315_CR25","first-page":"812","volume":"13","author":"NA Heidar","year":"2023","unstructured":"Heidar NA, Bhat TA, Shabir U, Hussein AA. The urinary microbiome and bladder cancer. Life Basel Switz. 2023;13(3):812.","journal-title":"Life Basel Switz"},{"issue":"6","key":"1315_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"issue":"1","key":"1315_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6(1):291.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1315_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"6264","key":"1315_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science. 2015;350(6264):1084\u20139.","journal-title":"Science"},{"issue":"6371","key":"1315_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"6161","key":"1315_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967\u201370.","journal-title":"Science"},{"issue":"6","key":"1315_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1315_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24(8):577\u201395.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"1315_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661\u201372.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"1315_CR35","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci. 2014;111(6):2247\u201352.","journal-title":"Proc Natl Acad Sci"},{"key":"1315_CR36","doi-asserted-by":"publisher","unstructured":"R\u00edos-Covi\u00e1n D, Ruas-Madiedo P, Margolles A, Gueimonde M, De Los Reyes-Gavil\u00e1n CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol [Internet]. 2016 Feb 17 [cited 2025 Sept 23];7. Available from: http:\/\/journal.frontiersin.org\/Article\/https:\/\/doi.org\/10.3389\/fmicb.2016.00185\/abstract.","DOI":"10.3389\/fmicb.2016.00185\/abstract"},{"issue":"83","key":"1315_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nutres.2020.08.009","volume":"1","author":"H Zeng","year":"2020","unstructured":"Zeng H, Hamlin SK, Safratowich BD, Cheng WH, Johnson LK. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention. Nutr Res. 2020;1(83):63\u201372.","journal-title":"Nutr Res"},{"key":"1315_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120573","volume":"300","author":"F Hersi","year":"2022","unstructured":"Hersi F, Elgendy SM, Al Shamma SA, Altell RT, Sadiek O, Omar HA. Cancer immunotherapy resistance: the impact of microbiome-derived short-chain fatty acids and other emerging metabolites. Life Sci. 2022;300:120573.","journal-title":"Life Sci"},{"issue":"8027","key":"1315_CR39","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41586-024-07754-w","volume":"632","author":"B Roje","year":"2024","unstructured":"Roje B, Zhang B, Mastrorilli E, Kova\u010di\u0107 A, Su\u0161ak L, Ljubenkov I, et al. Gut microbiota carcinogen metabolism causes distal tissue tumours. Nature. 2024;632(8027):1137\u201344.","journal-title":"Nature"},{"issue":"15","key":"1315_CR40","doi-asserted-by":"publisher","first-page":"1506319","DOI":"10.3389\/fonc.2025.1506319","volume":"21","author":"R Ginwala","year":"2025","unstructured":"Ginwala R, Bukavina L, Sindhani M, Nachman E, Peri S, Franklin J, et al. Bladder cancer microbiome and its association with chemoresponse. Front Oncol. 2025;21(15):1506319.","journal-title":"Front Oncol"},{"issue":"20","key":"1315_CR41","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.3390\/ijms252011157","volume":"25","author":"K Min","year":"2024","unstructured":"Min K, Zheng CM, Kim S, Kim H, Lee M, Piao XM, et al. Differential urinary microbiome and its metabolic footprint in bladder cancer patients following BCG treatment. Int J Mol Sci. 2024;25(20):11157.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1315_CR42","first-page":"3073","volume":"14","author":"S Jiang","year":"2022","unstructured":"Jiang S, Redelman-Sidi G. BCG in Bladder Cancer Immunotherapy Cancers. 2022;14(13):3073.","journal-title":"BCG in Bladder Cancer Immunotherapy Cancers"},{"issue":"3","key":"1315_CR43","first-page":"244","volume":"4","author":"FC von Rundstedt","year":"2015","unstructured":"von Rundstedt FC, Lerner SP. Bacille-Calmette-Guerin non-responders: how to manage. Transl Androl Urol. 2015;4(3):244\u201353.","journal-title":"Transl Androl Urol"},{"key":"1315_CR44","doi-asserted-by":"publisher","unstructured":"Tulone G, Pavan N, Fasciana MA, Campo L, Martorana A, Minasola C, et al. MP15\u201309 exploring the role of the bladder microbiome in bcg therapy outcomes for high-risk bladder cancer | Journal of Urology [Internet]. 2025 [cited 2025 Sept 24]. Available from: https:\/\/www.auajournals.org\/doi\/https:\/\/doi.org\/10.1097\/01.JU.0001109876.32161.cb.09.","DOI":"10.1097\/01.JU.0001109876.32161.cb.09"},{"issue":"9","key":"1315_CR45","first-page":"291.e1","volume":"42","author":"J Knorr","year":"2024","unstructured":"Knorr J, Lone Z, Werneburg G, Adler A, Agudelo J, Suryavanshi M, et al. An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. Urol Oncol Semin Orig Investig. 2024;42(9):291.e1-291.e11.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1315_CR46","doi-asserted-by":"publisher","unstructured":"Lone Z, Knorr J, Werneburg G, Adler A, Agudelo J, Campbell R, et al. PD25\u201308 the bladder tumor microbiome may augment response to BCG in non-muscle invasive bladder cancer. J Urol [Internet]. 2023 Apr [cited 2025 Sept 23];209(Supplement 4). Available from: http:\/\/www.auajournals.org\/doi\/https:\/\/doi.org\/10.1097\/JU.0000000000003303.08.","DOI":"10.1097\/JU.0000000000003303.08"},{"issue":"6356","key":"1315_CR47","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156\u201360.","journal-title":"Science"},{"key":"1315_CR48","doi-asserted-by":"publisher","unstructured":"Prasad SM, Shishkov D, Mihaylov NV, Khuskivadze A, Genov P, Terzi V, et al. Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). J Urol [Internet]. 2025 Feb [cited 2025 Sept 24]; Available from: https:\/\/www.auajournals.org\/doi\/https:\/\/doi.org\/10.1097\/JU.0000000000004296.","DOI":"10.1097\/JU.0000000000004296"},{"issue":"5","key":"1315_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.urolonc.2024.12.264","volume":"43","author":"S Daneshmand","year":"2025","unstructured":"Daneshmand S, Kamat AM, Shore ND, Meeks JJ, Galsky MD, Jacob JM, et al. Development of TAR-200: a novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer. Urol Oncol. 2025;43(5):286\u201396.","journal-title":"Urol Oncol"},{"issue":"4","key":"1315_CR50","first-page":"254","volume":"43","author":"M Golshani","year":"2025","unstructured":"Golshani M, Taylor JA, Woolbright BL. Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response. Urol Oncol Semin Orig Investig. 2025;43(4):254\u201365.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"1315_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12866-021-02407-8","volume":"22","author":"C Chen","year":"2022","unstructured":"Chen C, Huang Z, Huang P, Li K, Zeng J, Wen Y, et al. Urogenital microbiota:potentially important determinant of PD-L1 expression in male patients with non-muscle invasive bladder cancer. BMC Microbiol. 2022;22(1):7.","journal-title":"BMC Microbiol"},{"issue":"1","key":"1315_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03786-1","volume":"23","author":"A Braun","year":"2025","unstructured":"Braun A, Deng M, Hasler JS, Bukavina L, Handorf E, Abbosh PH. Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients. BMC Med. 2025;23(1):117.","journal-title":"BMC Med"},{"key":"1315_CR53","doi-asserted-by":"crossref","unstructured":"Fidelle M, Rauber C, Alves Costa Silva C, Tian AL, Lahmar I, de La Varende ALM, et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science. 2023;380(6649): 2296.","DOI":"10.1126\/science.abo2296"},{"issue":"1","key":"1315_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2224672","volume":"12","author":"M Fidelle","year":"2023","unstructured":"Fidelle M, Tian AL, Zitvogel L, Kroemer G. Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance. Oncoimmunology. 2023;12(1):2224672.","journal-title":"Oncoimmunology"},{"issue":"6510","key":"1315_CR55","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369(6510):1481\u20139.","journal-title":"Science."},{"issue":"6371","key":"1315_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"2","key":"1315_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","volume":"78","author":"L Derosa","year":"2020","unstructured":"Derosa L, Routy B, Fidelle M, Iebba V, Alla L, Pasolli E, et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur Urol. 2020;78(2):195\u2013206.","journal-title":"Eur Urol"},{"issue":"6529","key":"1315_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. Science. 2021;371(6529):595\u2013602.","journal-title":"Science"},{"issue":"1","key":"1315_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11884-016-0345-8","volume":"11","author":"K Thomas-White","year":"2016","unstructured":"Thomas-White K, Brady M, Wolfe AJ, Mueller ER. The bladder is not sterile: history and current discoveries on the urinary microbiome. Curr Bladder Dysfunct Rep. 2016;11(1):18\u201324.","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"1315_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euros.2023.11.003","volume":"59","author":"C Nardelli","year":"2024","unstructured":"Nardelli C, Aveta A, Pandolfo SD, Tripodi L, Russo F, Imbimbo C, et al. Microbiome profiling in bladder cancer patients using the first-morning urine sample. Eur Urol Open Sci. 2024;59:18\u201326.","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"1315_CR61","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.euo.2023.02.004","volume":"6","author":"L Bukavina","year":"2023","unstructured":"Bukavina L, Isali I, Ginwala R, Sindhani M, Calaway A, Magee D, et al. Global meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon\u2013degrading bacteria among bladder cancer patients. Eur Urol Oncol. 2023;6(2):190\u2013203.","journal-title":"Eur Urol Oncol"},{"issue":"9","key":"1315_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641921","volume":"29","author":"JL O\u2019Callaghan","year":"2021","unstructured":"O\u2019Callaghan JL, Willner D, Buttini M, Huygens F, Pelzer ES. Limitations of 16S rRNA gene sequencing to characterize lactobacillus species in the upper genital tract. Front Cell Dev Biol. 2021;29(9):641921.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1315_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/life12010059","volume":"12","author":"V Sankarapandian","year":"2022","unstructured":"Sankarapandian V, Venmathi Maran BA, Rajendran RL, Jogalekar MP, Gurunagarajan S, Krishnamoorthy R, et al. An update on the effectiveness of probiotics in the prevention and treatment of cancer. Life. 2022;12(1):59.","journal-title":"Life"},{"issue":"3","key":"1315_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2567.2007.02792.x","volume":"124","author":"SW Seow","year":"2008","unstructured":"Seow SW, Rahmat JN, Bay BH, Lee YK, Mahendran R. Expression of chemokine\/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Gu\u00e9rin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. Immunology. 2008;124(3):419\u201327.","journal-title":"Immunology"},{"key":"1315_CR65","doi-asserted-by":"publisher","unstructured":"Bao Y, Razvi H, Gloor G, Reid G, Denstedt J, Burton J. MP88\u201319 urinary microbiome patterns appears to be correlative to intravesical recurrence of non-muscle invasive bladder cancer. J Urol [Internet]. 2016 Apr [cited 2025 Sept 24]; Available from: https:\/\/www.auajournals.org\/doi\/https:\/\/doi.org\/10.1016\/j.juro.2016.02.2437.","DOI":"10.1016\/j.juro.2016.02.2437"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01315-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:03:07Z","timestamp":1768374187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01315-y","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/Animal Studies Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"8"}}